ATNM vs. VIR

Last updated Jun 24, 2026

ATNM (Actinium Pharmaceuticals, Inc.) and VIR (Vir Biotechnology, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ATNM returned -33.49%/yr vs -27.17%/yr for VIR. At a 0.26 correlation, their price movements are largely independent.

Performance

ATNM vs. VIR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Actinium Pharmaceuticals, Inc. (ATNM) and Vir Biotechnology, Inc. (VIR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ATNM achieves a -25.00% return, which is significantly lower than VIR's 68.49% return.

ATNM

• 1D: -0.97%
• 1M: -13.56%
• YTD: -25.00%
• 6M: -35.44%
• 1Y: -32.89%
• 3Y*: -48.60%
• 5Y*: -33.49%
• 10Y*: -32.45%

VIR

• 1D: 6.17%
• 1M: 10.55%
• YTD: 68.49%
• 6M: 69.62%
• 1Y: 101.19%
• 3Y*: -25.49%
• 5Y*: -27.17%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ATNM vs. VIR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ATNM Actinium Pharmaceuticals, Inc.	-25.00%	7.94%	-75.20%	-52.30%	77.20%	-22.95%	19.27%	11.22%
VIR Vir Biotechnology, Inc.	68.49%	-17.85%	-27.04%	-60.25%	-39.55%	56.35%	112.96%	-22.14%

Correlation

The correlation between ATNM and VIR is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.33
Correlation (All Time) Calculated using the full available price history since Oct 11, 2019	0.26

Fundamentals

Market Cap ATNM : $31.86M VIR : $1.50B
EPS ATNM : -$0.75 VIR : -$3.14
PS Ratio ATNM : 353.67 VIR : 21.87
PB Ratio ATNM : 13.83 VIR : 1.84
Total Revenue (TTM) ATNM : $90.00K VIR : $65.50M
Gross Profit (TTM) ATNM : $485.00K VIR : $183.11M
EBITDA (TTM) ATNM : -$24.68M VIR : -$448.10M

Return for Risk

ATNM vs. VIR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATNM

ATNM Risk / Return Rank: 20
ATNM Sharpe Ratio Rank: 20
ATNM Sortino Ratio Rank: 22
ATNM Omega Ratio Rank: 23
ATNM Calmar Ratio Rank: 16
ATNM Martin Ratio Rank: 17

VIR

VIR Risk / Return Rank: 83
VIR Sharpe Ratio Rank: 82
VIR Sortino Ratio Rank: 82
VIR Omega Ratio Rank: 77
VIR Calmar Ratio Rank: 87
VIR Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATNM vs. VIR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Actinium Pharmaceuticals, Inc. (ATNM) and Vir Biotechnology, Inc. (VIR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ATNM	VIR	Difference
Sharpe ratio: Return per unit of total volatility	-0.50	1.45	-1.96
Sortino ratio: Return per unit of downside risk	-0.47	2.34	-2.81
Omega ratio: Gain probability vs. loss probability	0.95	1.27	-0.32
Calmar ratio: Return relative to maximum drawdown	-0.69	3.66	-4.35
Martin ratio: Return relative to average drawdown	-1.15	8.34	-9.49

ATNM vs. VIR - Sharpe Ratio Comparison

The current ATNM Sharpe Ratio is -0.50, which is lower than the VIR Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of ATNM and VIR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ATNM vs. VIR - Drawdown Comparison

The maximum ATNM drawdown since its inception was -99.75%, which is greater than VIR's maximum drawdown of -94.85%. Use the drawdown chart below to compare losses from any high point for ATNM and VIR.

Drawdown Indicators

	ATNM	VIR	Difference
Max Drawdown Largest peak-to-trough decline	-99.75%	-94.85%	-4.90%
Max Drawdown (1Y) Largest decline over 1 year	-47.59%	-27.82%	-19.77%
Max Drawdown (3Y) Largest decline over 3 years	-90.09%	-82.86%	-7.23%
Max Drawdown (5Y) Largest decline over 5 years	-93.20%	-92.15%	-1.05%
Max Drawdown (10Y) Largest decline over 10 years	-98.37%	—	—
Current Drawdown Current decline from peak	-99.74%	-87.77%	-11.97%
Average Drawdown Average peak-to-trough decline	-85.42%	-67.82%	-17.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.75%	12.18%	+16.57%

Volatility

ATNM vs. VIR - Volatility Comparison

Actinium Pharmaceuticals, Inc. (ATNM) and Vir Biotechnology, Inc. (VIR) have volatilities of 16.73% and 16.76%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ATNM	VIR	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.73%	16.76%	-0.03%
Volatility (6M) Calculated over the trailing 6-month period	44.99%	48.81%	-3.82%
Volatility (1Y) Calculated over the trailing 1-year period	65.44%	70.06%	-4.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	79.87%	72.86%	+7.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	81.43%	95.99%	-14.56%

Dividends

ATNM vs. VIR - Dividend Comparison

Neither ATNM nor VIR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ATNM and VIR in my portfolio?

ATNM and VIR have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ATNM or VIR?

VIR has higher volatility (16.76%) compared to ATNM (16.73%). In terms of maximum drawdown, ATNM dropped -99.75% vs VIR's -94.85%.

Which has better risk-adjusted returns?

VIR currently has the higher Sharpe Ratio (1.45 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.